Project Grant R44TR003832
Award Date
4/1/21
Completion Date
3/31/24
Dollars Obligated
$6M
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This Project Grant award from the National Cancer Institute's Cancer Treatment Research program (CFDA 93.395) provides $159,574 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to increase access and participation to early phase clinical trials for underrepresented populations, including veterans. The project aims to develop sustainable strategies to extend access and boost participation in the Experimental Therapeutics Clinical Trials Network (ETCTN) clinical...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) aims to optimize and validate the Veris Health Cancer Care Platform for medically underserved cancer patients receiving outpatient chemotherapy. The $892,112 project will focus on making the platform culturally and linguistically appropriate, easy to use, and accessible for patients with language barriers, limited technology access, and...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $325,000 to Kairos Research LLC, a small disadvantaged business in Dayton, OH, to develop a mobile application to help Latino adolescents manage type 1 diabetes. The key products and services to be delivered under this 1-year award include optimizing the app design through end user research and internal testing (Aim 1), as well as...
This Project Grant award of $588,900 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) aims to address health disparities through the development of a quantitative physiological database and precision systems modeling for drug development and clinical evaluation. The key products and services to be delivered under this award include: 1) Creation of the Underrepresented Population Drug Target Protein (UPDTP)...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) in the amount of $297,000.00 will support a mixed methods study to understand the challenges and benefits of delivering new Alzheimer's disease (AD) drugs equitably to African American and white patients in Alabama. The objective is to assess access to care barriers, perceived value, and costs and benefits of new AD drugs for these two populations. In the initial R61 planning phase, the University of...
This Cooperative Agreement award from the Food and Drug Administration (FDA) under the FDA Research program (CFDA 93.103) provides $500,000 in funding to the University of North Carolina at Chapel Hill (UNC-CH) to establish the "Hybrid Operations to Promote Equity (HOPE)" initiative. The goal of this project is to address health disparities in North Carolina's diverse patient population by engaging local healthcare providers, implementing digital health tools, and developing...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $231,000.00 to the University of Rochester to develop and assess culturally-tailored approaches for improving equity in neurology palliative care research for Parkinson's disease, Lewy body dementia, and related disorders in Black and Hispanic communities. The project aims to: 1)...
This Project Grant award of $465,000 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) supports a study to compare technological and relational approaches to engage families who miss scheduled well-child visits. The study aims to: 1) demonstrate feasibility of integrating a new referral protocol for community health worker outreach after missed visits, 2) compare attendance rates after missed visits for...
This Cooperative Agreement awarded by the Food and Drug Administration (FDA) under CFDA Program 93.103 (Food and Drug Administration Research) provides $500,000 in funding to the University of Connecticut Health Center (UCHC) to integrate community voices into efforts to advance linguistic inclusion in clinical research. The project aims to: 1) Explore Spanish-speaking patients' perspectives, preferences, unmet needs, and barriers to participating in clinical trials; 2) Employ a participatory...
This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research program (CFDA 93.307), provides $3,947,731 to One Cow Standing, LLC to develop the HMP Next Gen digital health platform. The primary objectives are to: 1) streamline and expedite deployment of the platform through automated researcher-facing tools; 2) modernize and expand the platform's capabilities to facilitate study implementation,...